Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Chronic neuroblastoma.

Kushner BH, Kramer K, Cheung NK.

Cancer. 2002 Sep 15;95(6):1366-75.

2.
3.

Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse.

Raffaghello L, Marimpietri D, Pagnan G, Pastorino F, Cosimo E, Brignole C, Ponzoni M, Montaldo PG.

Cancer Lett. 2003 Jul 18;197(1-2):205-9. Review.

PMID:
12880983
4.

Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.

Kim JS, Kim JS, Kim SY, Kim Ki, Cho MJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1247-53. Review.

PMID:
12654434
5.

Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.

Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus K, Pomeroy SL, Turner CD, Chi SN, Chordas C, Kieran MW.

J Neurooncol. 2005 Mar;72(1):77-84. Review.

PMID:
15803379
6.

Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature.

Gow KW, Lensing S, Hill DA, Krasin MJ, McCarville MB, Rai SN, Zacher M, Spunt SL, Strickland DK, Hudson MM.

J Pediatr Surg. 2003 Nov;38(11):1574-80. Review.

PMID:
14614703
7.

Testicular and paratesticular involvement by metastatic neuroblastoma.

Simon T, Hero B, Berthold F.

Cancer. 2000 Jun 1;88(11):2636-41. Review.

PMID:
10861443
8.

Late recurrence in neuroblastoma.

Hata Y, Sasaki F, Naito H, Takahashi H, Namieno T, Uchino J.

J Pediatr Surg. 1991 Dec;26(12):1417-9. Review.

PMID:
1765927
9.

Neuroblastoma: Therapeutic strategies for a clinical enigma.

Modak S, Cheung NK.

Cancer Treat Rev. 2010 Jun;36(4):307-17. doi: 10.1016/j.ctrv.2010.02.006. Epub 2010 Mar 12. Review.

PMID:
20227189
10.

A comparative review of the immunobiology of murine neuroblastoma and human neuroblastoma.

Ziegler MM, Ishizu H, Nagabuchi E, Takada N, Arya G.

Cancer. 1997 May 1;79(9):1757-66. Review.

PMID:
9128993
11.

Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy.

Morgenstern DA, Baruchel S, Irwin MS.

J Pediatr Hematol Oncol. 2013 Jul;35(5):337-47. doi: 10.1097/MPH.0b013e318299d637. Review.

PMID:
23703550
12.

Late recurrence of neuroblastoma: a report of five cases and review of the literature.

Cervera A, Kingston JE, Malpas JS.

Pediatr Hematol Oncol. 1990;7(4):311-22. Review.

PMID:
2268531
13.
14.

[Familial neuroblastoma].

Nakamura M, Ohi R, Hayashi Y.

Nihon Rinsho. 1995 Nov;53(11):2684-7. Review. Japanese.

PMID:
8538026
15.

Neuroblastoma therapy: what is in the pipeline?

Verissimo CS, Molenaar JJ, Fitzsimons CP, Vreugdenhil E.

Endocr Relat Cancer. 2011 Nov 14;18(6):R213-31. doi: 10.1530/ERC-11-0251. Print 2011 Dec. Review.

16.

[Advances in the diagnosis and treatment of neuroblastoma].

Kavan P, Kouteck√Ĺ J.

Cas Lek Cesk. 1998 Apr 20;137(8):231-6. Review. Czech.

PMID:
9650346
17.

Adrenocorticotropic hormone in the aetiology and regression of neuroblastoma.

Tucker GR.

Med Hypotheses. 2002 Aug;59(2):117-28. Review.

PMID:
12208196

Supplemental Content

Support Center